Pepti · Catalog · PE-22-28

TREK-1 channel research · research-use

PE-22-28 OEM supply.

Spadin-derived heptapeptide (mini-spadin) and selective TREK-1 potassium-channel inhibitor, manufactured with per-lot COA, HPLC, and MS documentation for research and private-label programs.

PE-22-28 lyophilized vial
PE-22-28HPLC ≥ 98%MS confirmed10mg

Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.

CompoundPE-22-28
CAS number1801959-12-5
ClassNeuro & other
Molecular formulaC35H55N11O9
Molecular weight773.9 g/mol
SequenceGly-Val-Ser-Trp-Gly-Leu-Arg (GVSWGLR)
FormLyophilized powder, sterile glass vial
Purity target≥ 98% by HPLC
Vial formats10mg
DocumentationCOA + HPLC + MS, batch lot file where available
Distribution scopeResearch use, worldwide
StorageStore lyophilized powder at -20°C, protected from light and moisture; stable long-term when sealed. After reconstitution, keep at 2-8°C and use within a short period. Avoid repeated freeze-thaw cycles.

MOQ & lead time

TierQuantityLead time
Sample lotFrom 50 vials3–7 days
Production lot200–1,000 vials10–14 days
OEM repeat1,000+ vials14–18 days, scheduled

PE-22-28 is a synthetic spadin-derived heptapeptide (sequence GVSWGLR) that selectively inhibits the TREK-1 potassium channel, studied in preclinical neurogenesis and mood-related research models.

Documentation

Batch documentation support for PE-22-28 lots.

COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.

HPLC purity

Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.

MS identity

Mass spectrometry identity confirmation against the PE-22-28 reference profile.

Lot traceability

Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.

FAQ

PE-22-28 — frequently asked by B2B buyers.

What exactly is PE-22-28?

PE-22-28 is a synthetic heptapeptide (sequence GVSWGLR) corresponding to residues 22-28 of spadin, a sortilin-derived peptide, and is sometimes called mini-spadin. In preclinical research it is characterized as a selective TREK-1 potassium-channel inhibitor. All material is supplied strictly for laboratory and research use.

What purity and documentation do you provide?

Every lot ships with a Certificate of Analysis including RP-HPLC purity (typically >=98%) and mass-spectrometry identity confirmation matching the C35H55N11O9 / ~773.9 g/mol profile. Additional data such as residual-solvent, water-content, or endotoxin testing can be provided on request for OEM programs.

What vial size and MOQ are available?

The standard catalog format is 10 mg lyophilized vials with a minimum order of 50 vials. Custom fill weights and bulk quantities are quoted on RFQ for private-label and repeat buyers.

Can you private-label or customize PE-22-28?

Yes. We support OEM and private-label programs including custom vial fill, labeling, and packaging. Analogs and sequence modifications built on the GVSWGLR core can be scoped on RFQ, subject to feasibility review.

How is PE-22-28 shipped and handled for compliance?

Lyophilized material ships with documentation identifying it as a research-use-only chemical, not for human or veterinary use. Cold-chain or ambient shipping is selected by destination and transit time, and export paperwork is prepared per the buyer's jurisdiction.

WhatsApp us